These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22257687)

  • 1. The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence.
    Pussinen PJ; Sarna S; Puolakkainen M; Öhlin H; Sorsa T; Pesonen E
    Int J Cardiol; 2013 Jul; 167(2):362-8. PubMed ID: 22257687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of serum neutrophil markers and acute coronary syndrome.
    Alfakry H; Sinisalo J; Paju S; Nieminen MS; Valtonen V; Tervahartiala T; Pussinen PJ; Sorsa T
    Scand J Immunol; 2012 Aug; 76(2):181-7. PubMed ID: 22537345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EFFECT OF RELATIVE GENE EXPRESSION ON PLAQUE VULNERABILITY IN PATIENTS WITH STABLE ANGINA AND PATIENTS WITH ACUTE CORONARY SYNDROME.
    Chen N; Zhang JY; Yang SZ; Li YD
    J Biol Regul Homeost Agents; 2015; 29(2):437-41. PubMed ID: 26122234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men.
    Tuomainen AM; Nyyssönen K; Laukkanen JA; Tervahartiala T; Tuomainen TP; Salonen JT; Sorsa T; Pussinen PJ
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2722-8. PubMed ID: 17932311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum MMP-9 Diagnostics, Prognostics, and Activation in Acute Coronary Syndrome and Its Recurrence.
    Lahdentausta L; Leskelä J; Winkelmann A; Tervahartiala T; Sorsa T; Pesonen E; Pussinen PJ
    J Cardiovasc Transl Res; 2018 Jun; 11(3):210-220. PubMed ID: 29349668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The measurement of circulating matrix metalloproteinase-8 and its tissue inhibitor and their association with inflammatory mediators in patients with acute coronary syndrome.
    Allal-Elasmi M; Zayani Y; Zidi W; Zaroui A; Feki M; Mourali S; Mechmeche R; Kaabachi N
    Clin Lab; 2014; 60(6):951-6. PubMed ID: 25016699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Implications of serum matrix metalloproteinase-8 elevation in patients with acute coronary syndrome].
    Qiang H; Zhou ZX; Ma AQ; Cheng H; Zhou P
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):831-3. PubMed ID: 17584650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low MMP-8/TIMP-1 reflects left ventricle impairment in takotsubo cardiomyopathy and high TIMP-1 may help to differentiate it from acute coronary syndrome.
    Parkkonen O; Nieminen MT; Vesterinen P; Tervahartiala T; Perola M; Salomaa V; Jousilahti P; Sorsa T; Pussinen PJ; Sinisalo J
    PLoS One; 2017; 12(3):e0173371. PubMed ID: 28278213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
    Brunner S; Kim JO; Methe H
    Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome.
    Inokubo Y; Hanada H; Ishizaka H; Fukushi T; Kamada T; Okumura K
    Am Heart J; 2001 Feb; 141(2):211-7. PubMed ID: 11174334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months.
    Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Peros E; Fogari E; D'Angelo A
    Endothelium; 2007; 14(4-5):175-83. PubMed ID: 17922333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers.
    Giansante C; Fiotti N; Di Chiara A; Altamura N; Wasserman S; Fioretti P; Guarnieri G
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):602-7. PubMed ID: 17667031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription activity of MMP-2 and MMP-9 metalloproteinase genes and their tissue inhibitor (TIMP-2) in acute coronary syndrome patients.
    Dabek J; Glogowska-Ligus J; Szadorska B
    J Postgrad Med; 2013; 59(2):115-20. PubMed ID: 23793312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum tissue-degrading proteinases and incident cardiovascular disease events.
    Tuomainen AM; Kormi I; Havulinna AS; Tervahartiala T; Salomaa V; Sorsa T; Pussinen PJ
    Eur J Prev Cardiol; 2014 Jul; 21(7):806-12. PubMed ID: 23079500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood levels of matrix and inflammatory mediators are elevated in Tunisian patients with acute coronary syndromes.
    Zayani Y; Allal-Elasmi M; Jacob MP; Zidi W; Zaroui A; Feki M; Mourali S; Mechmech R; Kaabachi N
    Clin Lab; 2013; 59(1-2):169-75. PubMed ID: 23505923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
    Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE
    Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
    Peng Q; Zhou TF; Chen CH; Hua YM; Liu HM; Hong H; Zhang LY; Wu Q
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):676-80. PubMed ID: 16191301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome.
    Cheng M; Hashmi S; Mao X; Zeng QT
    Can J Cardiol; 2008 May; 24(5):385-90. PubMed ID: 18464944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
    Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
    J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
    Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
    Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.